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Sulfonucleotide reductases are a diverse family of enzymes that catalyze the first committed step of reductive sulfur
assimilation. In this reaction, activated sulfate in the context of adenosine-59-phosphosulfate (APS) or 39-
phosphoadenosine 59-phosphosulfate (PAPS) is converted to sulfite with reducing equivalents from thioredoxin. The
sulfite generated in this reaction is utilized in bacteria and plants for the eventual production of essential biomolecules
such as cysteine and coenzyme A. Humans do not possess a homologous metabolic pathway, and thus, these enzymes
represent attractive targets for therapeutic intervention. Here we studied the mechanism of sulfonucleotide reduction
by APS reductase from the human pathogen Mycobacterium tuberculosis, using a combination of mass spectrometry
and biochemical approaches. The results support the hypothesis of a two-step mechanism in which the sulfonucleotide
first undergoes rapid nucleophilic attack to form an enzyme-thiosulfonate (E-Cys-S-SO3
) intermediate. Sulfite is then
released in a thioredoxin-dependent manner. Other sulfonucleotide reductases from structurally divergent subclasses
appear to use the same mechanism, suggesting that this family of enzymes has evolved from a common ancestor.
Citation: Carroll KS, Gao H, Chen H, Stout CD, Leary JA, et al. (2005) A Conserved mechanism for sulfonucleotide reduction. PLoS Biol 3(8): e250.
Introduction
Carbon, nitrogen, and sulfur undergo energy cycles in our
environment that are essential to support life. While carbon
and nitrogen are available primarily as gases that require
fixation, sulfur occurs abundantly as inorganic sulfate.
Despite this apparent advantage, a substantial energetic
hurdle must still be overcome to convert the sulfur in its
most oxidized form into sulfide, the oxidation state of sulfur
required for the synthesis of essential biomolecules [1]. This
transformation is accomplished by a group of enzymes that,
together, make up the sulfate assimilation pathway [2].
We have studied the Mycobacterium tuberculosis sulfur
assimilation pathway (Figure 1) as a possible venue for novel
therapeutic targets [3]. In M. tuberculosis, ATP sulfurylase
(Figure 1, reaction a) activates inorganic sulfate via adenyla-
tion. The resulting compound, adenosine 59-phosphosulfate
(APS), contains a unique high-energy anhydride bond. This
vital intermediate resides at a metabolic hub within M.
tuberculosis. In the nonreductive branch of sulfate metabolism,
APS is phosphorylated a second time by APS kinase (Figure 1,
reaction b) to form 39-phosphoadenosine 59-phosphosulfate
(PAPS), the universal sulfate donor for sulfotransferases [4].
Alternatively, for the purposes of thiol or sulfide-containing
metabolite production mentioned above, APS is shuttled
through the reductive branch of this pathway (Figure 1,
reactions c1, d, and e).
In mycobacteria, APS reductase (Figure 1, reaction c1)
catalyzes the first committed step in the biosynthesis of
reduced sulfur compounds (Figure 2). In this reaction, APS is
reduced to sulfite and adenosine 59-phosphate (AMP) [5]. The
input of electrons, or reduction potential, necessary for this
reaction is provided by thioredoxin, a 12-kDa ubiquitous
protein cofactor [6–8]. Thioredoxin contains a -Cys-XX-Cys-
motif, and together these two cysteine residues form a redox-
active disulfide bond [9]. While other interesting functions
for thioredoxin have been reported, its most commonly
known role is participation in thiol/disulfide exchange
reactions, in which it donates electrons to proteins with
concomitant oxidation of its own thiols. Notably, APS
reductase has been identified in a screen for essential genes
in Mycobacterium bovis bacillus Calmette-Gue´rin [10]. Further-
more, in a murine model of tuberculosis infection, APS
reductase is critical for virulence (R. Senaratne, personal
communication). Since humans do not possess an analogous
enzyme, from a therapeutic standpoint, APS reductase
represents a unique target for antibiotic therapy.
The requirement for reduced sulfur in the biosynthesis of
cysteine, methionine, and other primary metabolites is
widespread among many organisms, such as algae, plants,
fungi, and a diverse array of bacteria [11–13]. However,
variations within this metabolic pathway exist, and interest-
ingly, not all organisms reduce APS. In a subtle change of
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substrate specificity, some organisms reduce PAPS (Figure 1,
reaction c2) as the source of sulfite (Figure 2) [14,15]. Known
collectively as sulfonucleotide reductases, this enzyme family
can be subdivided into three groups based on their substrate
specificity, cofactors, and domain organization (Figure 3A)
[11,12,16].
The first category of reductases consists of higher plants
(Figure 3A, group a), such as Arabidopsis thaliana and Lemina
minor [13,17,18]. These enzymes reduce APS. The main
characteristic that distinguishes this group from other
sulfonucleotide reductases is the presence of a 16 kDa
domain fused to the C-terminal end of the reductase, with
an extremely high degree of homology to thioredoxin—in
particular, the two redox-active cysteines. Notably, these
enzymes also possess an iron-sulfur cluster consisting of four
iron and four inorganic sulfur atoms (4Fe-4S) [18]. This
cluster is ligated by the cysteines found in the sequence motif
-CC-X; 80-CXXC-, although at present it is not clear whether
three or all four cysteines within this motif participate in
iron-sulfur cluster ligation [12,18]. On the other end of this
continuum are PAPS reductases (Figure 3A, group c) found in
c-proteobacteria and in fungi, such as Escherichia coli and
Saccharomyces cerevisiae, respectively [14,15]. In addition to
being distinct from the first class of reductases based on
substrate specificity, these enzymes lack the iron-sulfur
cluster cysteine motif and are thus devoid of this cofactor.
More recently, a new subclass of sulfonucleotide reductases
was discovered, designated as bacterial APS reductases
(Figure 3A, group b) [11]. Representative examples from this
group are found in organisms such as Mycobacterium tuber-
culosis, Pseudomonas aeruginosa, and Rhizobium meliloti. Interest-
ingly, another member of this subclass, from Bacillus subtilis,
can reduce PAPS in addition to APS [19]. These bacterial
enzymes possess a higher degree of homology to plant APS
reductases than to the bacterial PAPS reductases, particularly
in their absolute conservation of the iron-sulfur cluster
cysteine motif and 4Fe-4S cluster [12]. A dendrogram that
illustrates the amino acid sequence relationship between the
sulfonucleotide reductases described above is depicted in
Figure 3B. Their segregation at the primary sequence level
mirrors their substrate and cofactor distinctions.
Two fundamental questions remain unanswered for this
family of catalysts, each subgroup with its distinct cofactors,
substrate specificity and domain organization. Namely, at a
molecular level, how do sulfonucleotide reductases catalyze
this unique reaction and, on a broader level, do sulfonucleo-
tide reductases utilize similar or distinct catalytic mecha-
nisms? APS and PAPS reductases share a high degree of
Figure 1. Routes of Sulfate Assimilation
Inorganic sulfate is adenylated by ATP sulfurylase (reaction a) to form APS. Higher plants and the majority of sulfate reducing bacteria use APS as their
source of sulfite (reactions c1! d! e). In some organisms, APS kinase (reaction b) phosphorylates APS at the 39-hydroxyl group to form PAPS for use
as a sulfate donor for sulfotransferases or as a source of sulfite. The lower pathway of sulfate reduction (reactions c2 ! d ! e) is utilized by c-
proteobacteria such as E. coli and some fungi. Depending on the organism, APS or PAPS is reduced to sulfite by APS reductase (reaction c1) and PAPS
reductase (reaction c2), respectively. Sulfite is reduced to sulfide by sulfite reductase (reaction d) and incorporated into cysteine by O-acetylserine-(thiol)
lyase (reaction e). Important metabolites such as methionine and coenzyme A are, in turn, synthesized from cysteine.
DOI: 10.1371/journal.pbio.0030250.g001
Figure 2. Reaction Catalyzed by Sulfonucleotide Reductases
DOI: 10.1371/journal.pbio.0030250.g002
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sequence homology and possess an absolutely conserved
cysteine residue at the C terminus of the reductase domain
(Figure 3A). This cysteine residue does not play a role in iron-
sulfur cluster ligation, and mutation of this cysteine to serine
abolishes detectable catalytic activity [12,14,18]. From these
data, there is a general consensus on the essential catalytic
role of this cysteine residue.
In early studies using S. cerevisiae and E. coli PAPS
reductases, steady-state kinetics yielded parallel lines in
Lineweaver-Burk double reciprocal plots [14,15]. Such
results can be indicative of a ‘‘ping-pong’’ reaction
mechanism. The term ping-pong is used describe a
mechanism in which the enzyme first reacts with one
substrate to give a covalently modified enzyme and releases
one product [20,21]. The modified enzyme then reacts with a
second substrate in a subsequent step. In the case of
sulfonucleotide reductases, one substrate can be thought of
as the sulfonucleotide and the other, thioredoxin. For
simplicity, throughout the text we use the term ‘‘first step’’
to refer collectively to the steps that lead up to the
covalently modified enzyme and the term ‘‘second step’’ to
refer collectively to the steps subsequent to this modifica-
tion.
Several mechanisms have been proposed for the reduction
of both APS and PAPS. The fundamental difference between
these mechanisms lies in the specific role of thioredoxin
during the catalytic cycle. Initially, a model was hypothesized
in which thioredoxin would act in the first step of the
reaction catalyzed by PAPS reductase to reduce an inter-
molecular disulfide bond proposed to form between the two
C-terminal cysteine residues of the reductase homodimer
(Figure 4A) [14]. One of the liberated thiolates would
subsequently execute a nucleophilic attack on the sulfur
atom in PAPS, generating an enzyme-thiosulfonate inter-
Figure 3. Domain Organization and Cysteine Conservation within the Sulfonucleotide Reductase Family
(A) APS reductases from higher plants (group a) possess a reductase domain and a unique C-terminal domain with high homology to thioredoxin.
Bacterial APS reductases (group b) lack this specialized domain, but share the cysteine motif -CC-X;80-CXXC- present in the reductase domain. PAPS
reductases (group c) lack this cysteine motif as well as the thioredoxin domain. All sulfonucleotide reductases have a cysteine at the end of the C
terminus in the reductase domain. This residue is essential for catalysis.
(B) A dendrogram illustrating the sequence homology between enzymes within the sulfonucleotide reductase family. Each of the three subclasses of
sulfonucleotide reductases is clearly delineated: APS reductases from higher plants with their unique C-terminal thioredoxin domain (A. thaliana and L.
minor), bacterial APS reductases (M. tuberculosis, P. aeruginosa, and R. meliloti) and PAPS-reducing organisms (E. coli and S. cerevisae). Burkholderia
cepacia, Shigella flexneri, B. subtilis, and Bacillus anthracis were included for comparison. The sequence alignment was performed using ClustalW and the
tree was constructed with the Drawtree program [53].
DOI: 10.1371/journal.pbio.0030250.g003
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mediate, E-Cys-S-SO3
. In the second step, nucleophilic
attack by the second thiolate would generate a sulfite
product with concomitant reoxidation of the intermolecular
disulfide bond.
In a more recent study, it was proposed that APS reductase
from P. aeruginosa, and likely all bacterial APS reductases,
employ a slight variant of the PAPS reductase catalytic
strategy (Figure 4B) [22]. In this work, Kim and colleagues
suggested that thioredoxin reduces an intramolecular disul-
fide bond proposed to form between the C-terminal thiol in
the reductase domain and the second cysteine in the -CC-
sequence motif. The remainder of the reaction would
proceed as previously put forward for PAPS reductase; the
partner thiolate in the reduced disulfide bond would attack
the thiosulfonate intermediate to regenerate the intramolec-
ular disulfide and yield sulfite product.
An alternative mechanism has been suggested for the
reduction of APS in higher plants such as A. thaliana and
related organisms that possess the C-terminal thioredoxin
domain [23]. In this model, APS binds to the reductase in the
first step and forms an enzyme-thiosulfonate intermediate via
the essential C-terminal cysteine. In a subsequent step, the
authors propose that the thioredoxin domain would be
responsible for the release of bound sulfite. In a series of
experiments using only the N-terminal APS reductase
domain of the enzyme, Weber and colleagues convincingly
established the presence of a covalent sulfite adduct at the C-
terminal cysteine in the reductase domain [23]. Demonstra-
tion of a specific requirement for thioredoxin in product
release remained more elusive, as the N-terminally truncated
enzyme was only 3-fold more active in the presence of
recombinant thioredoxin m, as compared to dithiothreitol
(DTT) alone. A second thioredoxin, thioredoxin f, provided
no catalytic advantage over DTT. Furthermore, as this small
group of reductases from higher plants possessed different
domain organization from the bulk of the enzyme family, it
was unclear if the results from this work could be more
generally applied.
Herein, we describe experiments that draw upon a
combination of approaches—biophysical analysis, site-direc-
ted mutagenesis, kinetics, cysteine labeling, and direct
analysis of enzyme intermediates by Fourier transform ion-
cyclotron resonance (FT-ICR) mass spectrometry—to address
the question of mechanism in sulfonucleotide reductases.
Our results demonstrate that M. tuberculosis APS reductase
catalyzes the reduction of APS in a two-step process: In the
first step, APS undergoes rapid nucleophilic attack to form a
unique enzyme-thiosulfonate intermediate. In the second
step, thioredoxin mediates sulfite release.
We also investigated the mechanisms of other bacterial
APS reductases, including that from P. aeruginosa. In contrast
to previous suggestions, all bacterial APS reductases we
studied utilize the same general mechanism as we found for
M. tuberculosis APS reductase. Additionally, we have reex-
amined the mechanism proposed for PAPS reduction by E.
coli PAPS reductase. Like the APS reductases, E. coli PAPS
reductase forms an enzyme-thiosulfonate intermediate and
employs the same overall catalytic strategy as all other
sulfonucleotide reductases investigated in this study. Taken
together, these data suggest that the family of sulfonucleotide
reductases share the same general catalytic strategy and
provide functional evidence for evolution from a common
ancestor.
Results
The first mechanism proposed for sulfonucleotide reduc-
tion was generated from studies with S. cerevisiae and E. coli
PAPS reductases [14,15]. Both enzymes were isolated as
homodimers and possessed a single cysteine at their C
termini. It was proposed that reduction of a dynamic
intermolecular disulfide bond formed between the two C-
terminal cysteine residues initiated the catalytic cycle (Figure
4A). One of the liberated thiolates would attack the substrate
sulfur atom to form a thiosulfonate intermediate. Subsequent
attack by the second cysteine upon this intermediate would
regenerate the enzyme disulfide and produce sulfite. There
are four clear predictions from this model: (1) Sulfonucleo-
tide reductases should be homodimers; (2) In the first step of
the reaction, thioredoxin should reduce an intermolecular
disulfide bond between the catalytic cysteines; (3) A thiosul-
fonate enzyme intermediate should be formed; and (4) The
second thiolate should be essential for regeneration of the
proposed disulfide bond and the production of sulfite. As M.
tuberculosis APS reductase is a compelling target for drug
development, we wanted to test the various features of this
mechanism in order to better inform our efforts at rational
drug design.
M. tuberculosis APS Reductase Is a Monomer
We set out to confirm that M. tuberculosis APS reductase was
a dimer, but to our surprise, size exclusion chromatography
ofM. tuberculosis APS reductase indicated that this enzyme was
Figure 4. Previously Proposed Models of Sulfonucleotide Reduction
(A) Prior to covalent intermediate formation, thioredoxin (Trx) reduces an intermolecular disulfide bond [14,15].
(B) Prior to covalent intermediate formation, thioredoxin (Trx) reduces an intramolecular disulfide bond [22].
DOI: 10.1371/journal.pbio.0030250.g004
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a monomer (Figure S1A). Under the same conditions, E. coli
PAPS reductase eluted exclusively as the homodimer, as
reported in previous work (Figure S1A) [14]. To rule out the
possibility of anomalous migration on the gel filtration
column, we used analytical ultracentrifugation to determine
the molecular weight of M. tuberculosis APS reductase. Figure
5 depicts representative data from these experiments from a
sample containing 10 lM enzyme. Analysis of these data
yielded an estimated molecular weight for M. tuberculosis APS
reductase of 28,513 Daltons (Da). This value is in excellent
agreement with the expected molecular weight of the
holoenzyme, 28,705.88 Da. As an independent confirmation
of these results, an electrospray ionization (ESI) mass
spectrum was acquired for APS reductase. The enzyme was
sprayed in ammonium acetate buffer, a mild condition that
enables the analysis of the folded protein with retention of
noncovalently associated cofactors such as an iron-sulfur
cluster (referred to as ‘‘native mass analysis’’ throughout the
text) [24,25]. The mass spectrum of APS reductase showed a
charge distribution of 9þ, 10þ, and 11þ with a mass of
28,706.0 6 0.06 Da, corresponding to the monomeric protein
(Figure S1B).
To ensure that the histidine (His) tag was not disrupting
oligomerization, untagged M. tuberculosis APS reductase was
expressed and purified. This enzyme migrated with the same
retention volume on the size exclusion column as His-tagged
APS reductase (Figure S2A). To test for oligomerization in the
presence of substrate, AMP, or thioredoxin, M. tuberculosis
APS reductase was analyzed by successive runs on a gel
filtration column whose buffer contained a saturating
amount of the ligand or protein tested. There was no
evidence of dimerization under any condition (unpublished
data). APS reductase activity for the untagged and His-tagged
protein was also assayed across the protein elution profile of
the size exclusion column. In both cases, only a single peak of
activity was observed; the elution volume of this activity
corresponded to the monomeric molecular weight (Figure
S2). The specific activity of His-tagged and untagged M.
tuberculosis APS reductase using E. coli thioredoxin were 5.1
and 4.6 lmol min1 mg protein1, respectively. These values
are within range of those previously reported for APS
reductases from other organisms such as P. aeruginosa (5.8
lmol min1 mg protein1), R. meliloti (7 nmol min1 mg
protein1), B. subtilis (0.28 lmol min1 mg protein1), and A.
thaliana (30 lmol min1 mg protein1) [11,16,19,23]. Taken
together, these experiments demonstrate that the active form
of M. tuberculosis APS reductase is monomeric. Furthermore,
this finding was not confined to a single species as other
bacterial APS reductases such as those from Mycobacterium
smegmatis and R. meliloti were also isolated as monomers
(unpublished data). These data, in addition to the continuing
controversy regarding differing mechanisms proposed for
this family of enzymes, prompted us to investigate the
mechanism of M. tuberculosis and other sulfonucleotide
reductases in more detail.
M. tuberculosis APS Reductase Does Not Contain an
Intramolecular Disulfide Bond
One possible explanation for these data was that mono-
meric sulfonucleotide reductases might possess an intra-
molecular disulfide bond instead of an intermolecular
disulfide bond. Indeed, Kim and colleagues have recently
made this proposal to describe the catalytic behavior of P.
aeruginosa and bacterial APS reductases in general [22]. In this
slight variation of the original model, thioredoxin would
reduce an intramolecular disulfide bond in the first step with
all subsequent steps remaining the same (Figure 4B). To
investigate whether an intramolecular disulfide bond existed
inM. tuberculosis APS reductase, cysteine-labeling experiments
were carried out using 4-vinylpyridine (VP), a small and
highly specific reagent used to covalently modify free thiols.
After cysteine-labeling and buffer exchange to remove
unreacted reagent, the number of covalently modified
cysteines was determined by denatured mass analysis (treat-
ment of enzyme with 80% acetonitrile and 1% formic acid).
First, we confirmed that all six cysteines could be labeled in
the unfolded enzyme. When the enzyme was denatured with
guanidinium hydrochloride in the presence of the reducing
agent tris-(2-carboxyethyl)phosphine (TCEP), reaction with a
2-fold excess of VP over the total concentration of cysteine
residues resulted in five labeled cysteines. Reaction with a 10-
fold excess of reagent successfully labeled all six cysteines
(unpublished data). Next, we probed for cysteine modifica-
tions in the folded protein. Incubation of the native enzyme
with a 10-fold excess of VP under reducing conditions yielded
a molecular weight shift that corresponded to the addition of
only two vinyl pyridine labels (Table 1). No additional labels
were observed upon increasing the amount of VP to a 100-
fold excess over total cysteine concentration in the presence
of either TCEP or DTT. Moreover, no change in labeling was
observed when reductant was omitted from labeling reactions
(unpublished data). These results suggested that only two
reactive thiols were accessible within the folded M. tuberculosis
APS reductase protein.
From sequence gazing, we speculated that the two most
likely candidates responsible for the modifications were
Figure 5. M. tuberculosis APS Reductase Is a Monomer
Equilibrium sedimentation experiments of M. tuberculosis APS reductase
were performed using a Beckman Optima XL-I centrifuge at 4 8C. The
concentration of APS reductase shown in this figure was 10 lM.
However, as described in Materials and Methods, multiple concen-
trations of enzyme were analyzed, and in all cases we observed that the
enzyme was a monomer. Fitting the data to a model of a single ideal
species yielded a molecular mass of approximately 28.5 kDa.
DOI: 10.1371/journal.pbio.0030250.g005
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cysteine 59 (Cys59), a nonconserved cysteine present in the N-
terminal portion of the enzyme, and cysteine 249 (Cys249),
the most C-terminal cysteine and putative catalytic nucleo-
phile. To test whether these were indeed the cysteines
accessible to VP labeling, the same labeling experiments
were carried out with two cysteine-to-serine mutant enzymes.
Since VP does not label serine residues, mutation of Cys59 or
Cys249 to serine would result in the loss of a single label if
they represented the labeled species in the wild-type enzyme.
As predicted, each mutant resulted in the loss of precisely one
VP label (Table 1). Furthermore, no labels were obtained with
the double mutant Cys59Ser-Cys249Ser (Table 1). These
experiments confirmed the identity of the VP-modified
residues in the wild-type enzyme as Cys59 and Cys249.
The thiol labeling experiments demonstrated that M.
tuberculosis APS reductase contains two accessible cysteine
side chains that could, in theory, form an intramolecular
disulfide bond. However, when the molecular weight of native
M. tuberculosis APS reductase holoenzyme was evaluated by
native mass spectrometry, we found no evidence for the
presence of a disulfide bond, as the measured mass, in the
absence or presence of reductant, was 28,706.0 6 0.06 Da.
This mass is in excellent agreement with the theoretical value
of 28,705.88 Da, the predicted molecular weight for this
enzyme without an intramolecular disulfide bond. Further-
more, when we assayed the mutant enzymes for catalytic
activity, we found that Cys59 was entirely dispensable for
catalysis (Figure 6), which strongly suggests that no catalyti-
cally essential disulfide bond with this residue was formed. In
contrast, the Cys249Ser mutation resulted in an inactive
enzyme, as anticipated from previous work demonstrating
the essential nature of this residue (Figure 6). Taken together,
these experiments demonstrate that intramolecular disulfide
bond formation does not play a role in substrate reduction by
M. tuberculosis APS reductase.
A Stable Thiosulfonate Intermediate Is Formed in the
Absence of Thioredoxin
Prior work with sulfonucleotide reductases from other
organisms, as well as the data described above, had shown that
the C-terminal cysteine residue (Cys249) in the reductase
domain of M. tuberculosis APS reductase was essential for
activity [14,23]. However, we have also shown that this
cysteine is not involved in the formation of a disulfide bond
that would require reduction by thioredoxin prior to
substrate attack. We therefore considered the possibility that
this cysteine would act directly as a nucleophile in attacking
APS, without prior reduction by thioredoxin, to yield an
enzyme-thiosulfonate intermediate. While predicted by the
original model proposed for PAPS reduction, the existence of
such an intermediate has been under debate for some time in
Table 1. Mass Measurements of Wild-Type and Mutant M. tuberculosis APS Reductase Labeled with VP
Enzymea Measured Mass (Da)b Dmc,d Modification
WT 28,564.5 (28,564.6) 210.3 2 VP
C249S 28,443.3 (28,443.4) 105.2 1 VP
C59S 28,443.3 (28,443.4) 105.1 1 VP
C249S-C59S 28,322.2 (28,322.3) 0 N/A
WTþAPS 28,541.1 (28,541.4) 186.9 1 VP þSO3
C249SþAPS 28,443.3 (28,443.4) 105.2 1 VP
C59SþAPS 28,420.1 (28,420.3) 82.1 SO3
C249S-C59SþAPS 28,322.4 (28,322.3) 0 N/A
aIn reactions that contained APS, substrate was incubated with enzyme prior to addition of VP.
bMasses were calculated using the deconvolution function of the Bruker Xmass 6.0.0 software. Theoretical values are shown in parenthesis and were calculated based on amino acid sequence.
cIn this experiment, denatured mass analysis has been used to quantify the number of covalent cysteine modifications. Since the iron-sulfur cluster is noncovalently bound to APS reductase, during this procedure the iron-sulfur cluster
naturally dissociates from the enzyme to form the apoprotein. Thus, the mass differences in this table have been calculated with respect to the masses of the corresponding intact apoprotein.
dWith the exception of WTþAPS and C59SþAPS, we have observed the formation of a disulfide bond in the apoprotein that is not present in the holoprotein. This disulfide bond results from oxidation of the cysteinyl sulfur atoms that are
responsible for binding the iron-sulfur cluster. This phenomenon has also been documented for other iron-sulfur proteins [24, 25]. While it is intriguing that the apoprotein-thiosulfonate intermediate species did not form this internal disulfide,
it does not occur in the active holoenzyme nor does it alter the interpretation of these labeling experiments. Taking the disulfide bond into account, the expected mass difference for the sulfite modification isþ82 Da with respect to the
oxidized apoproteins.
N/A, not applicable.
DOI: 10.1371/journal.pbio.0030250.t001
Figure 6. Cysteine 59 Is Not Required for M. tuberculosis APS Reductase
Activity
The activity of wild-type (closed circles), Cys59Ser (open circles) and
Cys249Ser (closed squares) APS reductase was determined as described
in Materials and Methods. The concentration of sulfonucleotide
reductase in this experiment was 10 nM and the concentration of APS
was 20 lM.
DOI: 10.1371/journal.pbio.0030250.g006
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the sulfonucleotide reductase literature [15,22,23,26]. Incu-
bation of APS with a truncated version of A. thaliana APS
reductase under physiological conditions yielded a sulfite
bound to the C-terminal cysteine within the reductase
domain [23]. Despite these intriguing data, no definitive
evidence for such an intermediate has been presented for any
bacterial APS or PAPS reductase.
WithM. tuberculosis APS reductase, we hypothesized that the
intermediate could be accumulated simply by omitting
thioredoxin from the reaction. In order to test this model,
we used mass spectrometry to probe for modifications to the
enzyme during the reaction. In these experiments, APS was
incubated with enzyme in ammonium acetate buffer; the
mixture was sprayed directly for native mass spectrometry
analysis. As reported above, the mass spectrum of APS
reductase in the absence of substrate is characterized by a
major series of ions with a molecular weight corresponding to
the holoenzyme (Figure 7A, solid circles). Coincubation of
APS reductase and APS resulted in the formation of a new
series of ions with a molecular weight approximately 80 Da
higher than the holoenzyme (Figure 7A, asterisks). Moreover,
the signal of these ions intensified in response to increasing
APS concentration. High-resolution FT-ICR mass analysis of
the new species confirmed a mass shift of þ80.04 6 0.07 Da
relative to the holoenzyme, consistent with the molecular
weight expected for a covalently bound sulfite. Finally,
proteolytic digest of the intermediate followed by mass
analysis of the resulting peptides confirmed the exact mass
difference of þ80 Da relative to the unmodified peptide
(Figure 7B). Thus, the simplest interpretation of these data is
that incubation of substrate with enzyme produces a
covalently bound sulfite modified intermediate.
To support the mass spectrometry findings, biochemical
assays were also performed. Incubation of [35S]-labeled APS
together with enzyme, and subsequent analysis of the reaction
by nonreducing SDS-PAGE, produced a single radioactive
band—indicating the transfer of the 35S label from the
substrate to the enzyme—at the expected molecular weight
for APS reductase (Figure S3, lane 1). This radiolabel could be
eliminated in the unfolded enzyme by heat in combination
with b-mercaptoethanol (unpublished data). Likewise, pre-
incubation of enzyme with saturating amounts of non-
radioactive substrate prior to addition of [35S]APS, blocked
radiolabeling (Figure S3, lane 2). Taken together, these data
demonstrate the formation of a stable thiosulfonate enzyme-
intermediate in M. tuberculosis APS reductase.
In the mass spectrometry analysis of APS reductase
incubated with APS, we also detected a third series of ions
with a calculated mass corresponding to the holoenzyme plus
427 Da (Figure 7A, triangles). The additional 427 Da could
represent the intact holoenzyme bound to unreacted sub-
strate, APS. Alternatively, this species could represent the
enzyme-thiosulfonate intermediate bound to the second
product, AMP. To distinguish between these two possibilities,
we carried out solution kinetic experiments using conditions
identical to those used for mass spectrometry to measure the
rate at which substrate was converted to intermediate. By the
first measurable time point (15 s), all substrate had been
consumed, suggesting that the þ427 Da ion was not due to
binding of unreacted substrate (unpublished data). There-
fore, the simplest interpretation of these data is that the third
ion represents APS reductase bound covalently to sulfite and
noncovalently to the product, AMP. Finally, in this experi-
ment we also observed two minor series of ions whose
molecular weights were less than the holoenzyme (Figure 7A,
dashed lines). The mass of these ions was 28,352.4 Da and
26,529.3 Da. It has been well established that iron-sulfur
clusters are vulnerable to oxidation and dissociation from
their protein scaffolds [18,19,25,27]. For M. tuberculosis APS
reductase, the theoretical mass for the apoenzyme (enzyme
without iron-sulfur cluster) is 28,352.2 Da and for the 2Fe-2S
intermediate it is 28,529.1 Da. These values are within 0.2 Da
of the measured masses of the ions noted above. Therefore, a
likely possibility is that these ions represent different stages
in cluster decomposition of APS reductase. In contrast to the
holoenzyme, these lower molecular weight ions did not
exhibit any mass shift upon the addition of APS.
The Thiosulfonate Intermediate Is Bound to the C-
Terminal Cysteine
To test whether the C-terminal cysteine, Cys249, was
essential for the formation of the enzyme-sulfite intermedi-
ate, we carried out experiments analogous to those above
with the Cys249Ser mutant. If Cys249 is the nucleophile for
attack on APS, the Cys249Ser mutant should not form the
enzyme-sulfite intermediate. In these experiments, APS was
incubated with the Cys249Ser mutant APS reductase. When
this reaction was analyzed by native mass spectrometry, the
mutant protein exhibited a mass shift ofþ427 Da, consistent
with the molecular weight of APS (Figure 8A). However,
despite the ability of the mutant to bind APS, this variant did
not form the thiosulfonate enzyme-intermediate. In separate
experiments, after incubation with substrate, the Cys249Ser
mutant enzyme was treated with 80% acetonitrile and 1%
formic acid to unfold the protein and protonate the side
chains for denatured mass spectrometry analysis. This treat-
ment resulted in release of the noncovalently bound APS
from the mutant enzyme, and only the intact apoprotein was
observed (Figure 8A, inset). In contrast, native mass analysis
of the reaction between APS and wild-type APS reductase
yielded the expected thiosulfonate-enzyme intermediate.
Subsequent analysis of this intermediate under denaturing
conditions demonstrated that the sulfite modification per-
sisted, as expected for a covalently bound intermediate
(Figure 8B; Figure 8B, inset).
As an independent confirmation of these results and a
more direct demonstration that the sulfite was attached
specifically to Cys249, cysteine-labeling experiments were
carried out with wild-type APS reductase and the two
mutants, Cys59Ser and Cys249Ser, using VP as a probe of
cysteine reactivity after incubation with APS. If the sulfite
intermediate were bound to Cys249, this residue would be
unreactive toward VP labeling. Therefore, in the presence of
substrate, both wild-type and Cys59Ser enzymes should lose a
single VP label with a concomitant gain of a sulfite, while
Cys249Ser should only lose a single VP label. When the
products of these reactions were analyzed by denatured mass
spectrometry, each of these expectations was confirmed
(Table 1). Finally, when Cys249Ser was incubated with [35S]-
labeled APS and analyzed by nonreducing SDS-PAGE, no
radiolabeled protein resulted (Figure S3, lane 4), in contrast
to Cys59Ser (Figure S3, lane 7) and wild-type enzyme (Figure
S3, lane 1). These data demonstrate that the C-terminal
cysteine residue (Cys249) is essential for intermediate
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formation, and confirm that the sulfite was bound to this
catalytic cysteine.
Thioredoxin Is Not Required for Intermediate Formation
but for Product Formation
The previous experiments suggested that incubation of
substrate together with enzyme is sufficient to form the
thiosulfonate enzyme-intermediate. The simplest interpreta-
tion of these data is that formation of the covalent
intermediate occurs prior to a step that requires thioredoxin.
Two predictions from this model are that (1) one equivalent
of covalent intermediate per equivalent of active enzyme is
formed in the absence of thioredoxin, and (2) the addition of
thioredoxin will lead to product formation and turnover of
the enzyme.
To test the first prediction, we quantified formation of
thiosulfonate enzyme-intermediate as a function of APS
reductase concentration. The data from this experiment are
shown in Figure 9; for ease of analysis we have plotted the
ratio of enzyme to substrate concentration (E:S) as the x-
coordinate. The fraction of intermediate formed increased
linearly with enzyme concentration. At an equimolar
concentration of enzyme and substrate, 80% of the substrate
would be converted into the covalent intermediate. Deple-
tion of substrate at an exact one-to-one ratio of enzyme to
substrate would require that our enzyme preparation
contain 100% active molecules. Thus, taking into account
that oxidation of the iron-sulfur cluster results in inactive
enzyme (see Figure 7) [18,19], these experiments show that
the fraction of covalent intermediate formed relative to
enzyme concentration is robust and relevant to the
mechanism.
The second prediction of our model is that thioredoxin will
reduce the enzyme-thiosulfonate intermediate to form
product. This hypothesis was first tested using native mass
analysis. In the absence of substrate, the spectrum of APS
reductase was characterized by three series of ions; the major
series of ions corresponded to the holoenzyme (Figure 10).
Upon supplementation with substrate, the enzyme-thiosulfo-
nate intermediate was formed. Addition of reduced, but not
oxidized, thioredoxin resulted in the release of the inter-
mediate. Control experiments demonstrated that release of
sulfite was not due to residual DTT in the reduced
thioredoxin sample (unpublished data).
Solution kinetics and gel-labeling experiments were also
performed to verify these mass spectrometry data. Addition of
thioredoxin to a reaction mixture containing APS reductase
and APS enabled multiple turnover of substrate (Figure 11).
Sulfite was not released by the addition of high concentrations
of DTT in place of thioredoxin as the reductant. Additionally,
a panel of small-molecule reductants with varying reduction
potentials was screened for their ability to release sulfite from
Figure 7. M. tuberculosis APS Forms a Thiosulfonate-Enzyme Intermedi-
ate in the Absence Thioredoxin
(A) ESI mass spectra in low resolution showing the titration of APS
reductase with APS in 50 mM NH4OAc (pH 7.5). In tracings labeled a to e,
the concentration of APS was 0, 1, 2, 4, and 10 lM, respectively. The
concentration of APS reductase is 15 lM in all cases. Peaks indicate ions
corresponding to the 10þ charge states of the enzyme (E, solid circles),
the covalent intermediate (E-SO3
, asterisks), and the noncovalent
complex between the intermediate and AMP (E-SO3
  AMP, triangles).
The dashed lines highlight the ions of APS reductase that lack a mature
iron-sulfur cofactor. The concentrations of APS reductase reported in this
figure were measured prior to mass analysis. A small fraction of protein
loss occurs during the mass analysis, and thus the reported concen-
trations of protein should be treated as an upper limit.
(B) ESI mass spectra of trypsin-digested APS reductase incubated with a
10-M excess of APS. The C-terminal peptide (T27, residues 247–262)
containing Cys249 showed a þ80 Da shift (right tracing) corresponding
to the molecular weight of a sulfite compared to the unmodified peptide
(left tracing). The measured m/z values of the peptide with and without
bound sulfite are indicated in the spectra. Shown in parenthesis are the
theoretical values.
DOI: 10.1371/journal.pbio.0030250.g007
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the intermediate. In each case, APS reduction was below our
detection limit over the time scale of the experiment ( 105
min1, unpublished data). Finally, gel-labeling experiments
demonstrated that incubation of [35S]-SO3
2 radiolabeled
reductase together with thioredoxin resulted in release of the
radiolabel, as expected (Figure S3, lanes 3 and 9). These
experiments demonstrated that efficient turnover of APS
specifically requires thioredoxin.
Sulfonucleotide Reduction Revisited
Given the results for M. tuberculosis APS reductase and their
consistency with the mode of action proposed for A. thaliana
APS reductase, we wondered whether all sulfonucleotide
reductases utilized the same overall catalytic strategy. To
further test this hypothesis, we chose to investigate E. coli
PAPS reductase and P. aeruginosa APS reductase, which have
been proposed to act via the mechanisms presented in Figure
4A and 4B, respectively.
With these two enzymes, we performed mass spectrometry
analysis and biochemical characterization similar to that
described for M. tuberculosis APS reductase. First, we probed
for thiosulfonate formation. Like M. tuberculosis APS reduc-
tase, both E. coli PAPS reductase and P. aeruginosa APS
reductase formed the enzyme-thiosulfonate intermediate
without prior reduction by thioredoxin (Table 2). As
expected, mutation of the catalytic cysteine in each enzyme
to serine prevented intermediate formation (Table 2). Also
consistent with M. tuberculosis APS reductase, the covalently
bound sulfite was released upon addition of reduced
thioredoxin and not by DTT (Table 2). These conclusions
were further corroborated as described above for M. tuber-
culosis APS reductase using data obtained from gel-labeling
and biochemical assays (Figures S4 and S5). Finally, two
additional bacterial APS reductases from R. meliloti and M.
smegmatis were analyzed in similar biochemical experiments
(unpublished data). These studies reiterated the findings
observed with all other sulfonucleotide reductases analyzed in
this study—the reaction proceeded via the covalent sulfite-
bound intermediate; sulfite production was dependent upon
reduction of this intermediate by thioredoxin.
To complete our analysis, we carried out cysteine-labeling
with E. coli PAPS reductase and P. aeruginosa APS reductase
using VP. Since E. coli PAPS reductase contains only one
cysteine residue in its amino acid sequence, incorporation of
one VP label was clearly predicted. A single label was obtained
and, as described for M. tuberculosis APS reductase, this
labeling could be blocked by preincubation of substrate and
enzyme prior to the addition of VP (Table 3). The primary
Figure 8. M. tuberculosis APS Reductase Cys249Ser Mutant Enzyme Binds
APS, but Does Not Form a Covalent Intermediate
ESI mass spectra of 20 lM Cys249Ser APS reductase with 20 lM APS (A)
and wild-type enzyme (B) with 5 lM APS in 50 mM NH4OAc (pH 7.5).
Insets: The corresponding deconvoluted spectra acquired in 80%
acetonitrile showing the presence and absence of a covalent modifica-
tion to the mutant and wild-type enzymes, respectively.
DOI: 10.1371/journal.pbio.0030250.g008
Figure 9. Covalent Enzyme-Intermediate Formation Is Stoichiometric
with APS Reductase
The fraction of APS converted to thiosulfonate enzyme-intermediate was
monitored as a function of APS reductase concentration as described in
the Materials and Methods. The concentration of APS in each reaction
was 0.5 lM. Enzyme concentration was varied between 0 and 1.25 lM.
The dashed line is a theoretical fit of the fraction intermediate formed
and its dependence upon enzyme concentration to a linear equation (R 2
 0.98).
DOI: 10.1371/journal.pbio.0030250.g009
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amino acid sequence of P. aeruginosa APS reductase contains
five cysteine residues, four from the -CC-X; 80-CXXC-
sequence motif and one from the C-terminal cysteine
nucleophile. When P. aeruginosa APS reductase was incubated
with VP and the reaction products were analyzed by mass
spectrometry, as in the labeling studies with E. coli and M.
tuberculosis reductases, only a single VP label was observed
(Table 3). To ensure that this pattern of labeling was not an
artifact specific to VP modification, we repeated the experi-
ments with iodoacetamide, another cysteine-modifying re-
agent. As in labeling studies with VP, a single label was
obtained with iodoacetamide under reducing or oxidizing
conditions (unpublished data). Site-directed mutagenesis as
well as preincubation of the enzymes with substrate prior to
VP addition positively identified the labeled residue as the C-
terminal cysteine (Tables 2 and 3). These experiments provide
no evidence to support the existence of a catalytic disulfide
bond in either E. coli PAPS reductase or P. aeruginosa APS
reductase. Moreover, based on the predictions made by the
models presented in Figure 4A and 4B, reoxidation of such a
disulfide bond would preclude the isolation of a stable
enzyme-thiosulfonate intermediate and directly contradict
the observed requirement for thioredoxin in sulfite release.
These results demonstrate in E. coli PAPS and P. aeruginosa APS
reductases that (1) incubation of sulfonucleotide reductase
together with substrate yields a covalent thiosulfonate-enzyme
intermediate; (2) intermediate formation is not dependent
upon prior reduction of the sulfonucleotide reductase by
thioredoxin; and (3) thioredoxin is essential for reduction of
the thiosulfonate intermediate.
Discussion
Over the last decade, a large body of work has contributed
substantially to our understanding of the unique family of
sulfonucleotide reductase enzymes. The authors of these
studies have proposed models for sulfonucleotide reduction
that have predictive power. We have anchored our studies by
systematically testing some of the central predictions from
the leading models previously proposed for sulfonucleotide
reduction. In this study, we have used new experimental
approaches to investigate this reaction from a different
perspective—namely, through the use of high-resolution FT-
ICR mass spectrometry in conjunction with cysteine-labeling,
solution-based kinetic analysis, and other biochemical ap-
proaches. Our results strongly suggest that a general catalytic
strategy is shared by all sulfonucleotide reductases and
provide the first functional evidence for evolution from a
common ancestor.
A Universal Mechanism for Sulfonucleotide Reduction
The data presented in this paper demonstrate that each of
the bacterial sulfonucleotide reductases operates via a two-
step mechanism, as originally proposed by Weber and
coworkers to describe APS reduction in higher plants [23].
In Figure 12, we take the original proposal by Weber and
coworkers a step further and provide a detailed picture of the
molecular events that might take place during sulfonucleo-
tide reduction. During the first step, an absolutely conserved
cysteine residue carries out nucleophilic attack on the
sulfonucleotide sulfate group to yield an enzyme-thiosulfo-
nate intermediate. The stable formation of this intermediate
has been demonstrated for each enzyme investigated here. In
all cases, addition of substrate to enzyme with subsequent
analysis of the reaction mixture by mass spectrometry yielded
holoenzyme with a molecular weight shift that corresponds
the covalent addition of a sulfite group (see Figures 7 and 8;
Table 2). Additionally, gel-labeling experiments have demon-
strated the requisite transfer of radiolabel from [35S]-
substrate to enzyme (Figures S3 and S4). We have also shown
through site-directed mutagenesis and cysteine-labeling
studies that the conserved nucleophile is not only essential
for intermediate formation, but is also the site of sulfite
attachment (see Figures 8, S3, and S4; Tables 2 and 3). Pre-
steady state kinetic analysis shows that sulfonucleotide
reductases are blocked after covalent intermediate formation
in the absence of thioredoxin and cannot perform multiple
rounds of substrate turnover (see Figures 9 and S5). Finally,
Figure 10. Thioredoxin Reduces the Thiosulfonate Enzyme-Intermediate
ESI mass spectra, in low resolution, of 10 lM APS reductase (A); 2.5 lM
APS and 10 lM APS reductase (B); 2.5 lM APS, 3.7 lM oxidized
thioredoxin, and 10 lM APS reductase (C); and 2.5 lM APS, 3.7 lM
thioredoxin reduced with 33 lM DTT, and 10 lM APS reductase (D). The
ions corresponding to the 10þ charge state of the enzyme-associated
species are labeled.
DOI: 10.1371/journal.pbio.0030250.g010
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native mass analysis of M. tuberculosis APS reductase demon-
strates that there are no disulfide bonds in the holoenzyme or
in the thiosulfonate enzyme-intermediate; cysteine-labeling
studies further support this conclusion for each of the
sulfonucleotide reductases analyzed in this work (see Tables
1 and 3). Taken together, these experiments demonstrate that
thioredoxin is not required for sulfonucleotide binding and
enzyme-thiosulfonate intermediate formation.
In the second half of the reaction, we demonstrated that
thioredoxin is required for product formation. Mass spec-
trometry and gel-labeling experiments clearly show the
resolution of thiosulfonate enzyme-intermediate with con-
comitant regeneration of free sulfonucleotide reductase
when thioredoxin is included in the reaction mixture (see
Figures 10, 11, and S5; Table 2). In addition, these studies
demonstrate that reduction of the thiosulfonate bond
requires thioredoxin; DTT by itself does not efficiently
support the reduction of the intermediate (see Figures 10,
11, and S5; Table 2). In the final steps of the reaction, we
propose that the more reactive N-terminal thioredoxin
cysteine would carry out nucleophilic attack upon the
sulfonucleotide reductase catalytic cysteine (Figure 12) [9].
This reaction would result in the formation of a mixed
disulfide between thioredoxin and the sulfonucleotide reduc-
tase and, concomitantly, release sulfite. Subsequent thiol/
disulfide exchange with the second thioredoxin thiolate
would yield oxidized thioredoxin and regenerate reduced
sulfonucleotide reductase. The proposed covalent protein-
protein intermediate is reminiscent of those predicted during
the thioredoxin-mediated reduction of protein disulfides [9].
However, the subsequent chemical step is very rapid and we
find no evidence for accumulation of this species. This result
is not unexpected, because of the intramolecular nature of
this reaction; we are currently using different experimental
approaches to test this aspect of the proposed model in
greater experimental detail.
A commonly employed assay to measure sulfonucleotide
reductase includes the addition of 20–40 mM nonradioactive
sulfite during the reaction or at its conclusion [13,28]. In their
work with A. thaliana APS reductase, Weber et al. [23]
demonstrated that the sulfite bound to the C-terminal
cysteine is released upon exposure to millimolar concen-
trations of sulfite, a natural reductant. We have reiterated
these findings in our own studies (unpublished data). Thus,
the inclusion of sulfite in the assay of sulfonucleotide
reductase activity results in thioredoxin-independent reduc-
tion of a thiosulfonate enzyme-intermediate to produce
sulfite. It is likely that this phenomenon has hampered prior
discovery of the covalent intermediate in bacterial sulfonu-
cleotide reductases, and can account for the modest activity
observed in the absence of thioredoxin reported by previous
studies [11,12,14].
A Novel Enzyme-Thiosulfonate Intermediate
The thiosulfonate species (E-Cys-S-SO3
) formed during
sulfonucleotide reduction is novel among the diverse array of
characterized covalent enzyme intermediates. The most
closely related covalent enzyme-intermediate is the persulfide
(E-Cys-S-S) found in the family of NifS-like enzymes that
includes NifS from Azotobacter vinelandii and E. coli IscS [29,30].
These catalysts have cysteine desulfurase activity that is
utilized to mobilize sulfur from L-cysteine [29–31]. The sulfur
Figure 11. Sulfite Release Is Thioredoxin-Dependent
Comparison of substrate turnover for M. tuberculosis APS reductase
supplemented with 10 lM thioredoxin (closed circles), with 10 mM DTT
(open circles), or in the absence of all reductants (closed squares) as
described in the Materials and Methods. The concentration of APS
reductase in this experiment was 5 nM, and of APS was 20 lM.
DOI: 10.1371/journal.pbio.0030250.g011
Table 2. Mass Measurements of Wild-Type and Mutant E. coli and P. aeruginosa Reductases Reacted with Substrate, in the Absence or
Presence of Thioredoxin
Enzyme Enzymea Only With APSb With APS and DTTb With APS, DTT, and Thioredoxin
Wild-type E. coli reductase 30,007.2 (30,007.5) 30,087.3 (þ80) 30,087.5 (þ80) 30,007.0
Cys239Ser E. coli reductase 29,991.2 (29,991.5) 29,991.5 N/A N/A
Wild-type P. aeruginosa reductase 31,279.6 (31,279.7) 31,359.7 (þ80) 31,359.5 (þ80) 31,279.6
Cys256Ser P. aeruginosa reductase 31,263.7 (31,263.6) 31,263.3 N/A N/A
Masses (reported in Da) were calculated using the deconvolution function of the Q-TOF micro Masslynx software.
aThe theoretical values are shown in parenthesis and were calculated based on amino acid sequence.
bThe mass differences calculated with respect to the masses of corresponding intact
proteins are shown in parenthesis.
N/A, not applicable.
DOI: 10.1371/journal.pbio.0030250.t002
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is bound to a conserved active site cysteine residue fromwhich
is it subsequently transferred to form a persulfide group on a
variety of other targets, such as the scaffold proteins NifU and
IscU, for use in the assembly of iron-sulfur clusters [32]. In
addition to cluster formation, NifS-like enzymes are also
required for other biological processes such as the biosyn-
thesis of thiamin, biotin, and molybdenum cofactors [32,33].
Another catalyst that has been demonstrated to form a
persulfide intermediate is the sulfur transferase rhodanese.
Like NifS-like proteins, this enzyme cycles between a sulfur-
free and a stable persulfide-containing form [34]. In vitro, it
has been demonstrated that rhodanese can act as a sulfur
insertase and regenerate iron-sulfur clusters in proteins [35].
However, the in vivo role of rhodanese has not been well
established. Notably, the structure of sulfur-free rhodanese
and its persulfide-containing form have been solved for a
number of organisms [34,36]. A comparison of the two enzyme
species indicates a significant conformational rearrangement
in the vicinity of the catalytic cysteine upon persulfide
formation. By analogy, a similar conformational change could
occur upon thiosulfonate formation in sulfonucleotide
reductases that would facilitate the recognition and subse-
quent reduction of this intermediate by thioredoxin.
Another related protein modification is the oxidation of
cysteine to sulfenic acid (R-S-OH) [37]. This oxidation is
reversible and can be reduced by thioredoxin and gluta-
thione. Cysteines can also be hyperoxidized to sulfinic (R-
SO2H) and sulfonic acids (R-SO3H) [37,38]. This process is
thought to occur by reaction of susceptible cysteine residues
with oxidizing metabolic byproducts, such as hydrogen
peroxide. A family of enzymes known as the peroxiredoxins
is reversibly inactivated by hyperoxidation of a cysteine
residue to the corresponding sulfinic acid in vivo [39,40]. A
protein termed sulfiredoxin was later identified and can
reduce this sulfinic acid modification back to cysteine [41].
Finally, in humans sulfite is thought to be detoxified by
conversion to S-sulfocysteine (Cys-S-SO3
) [42]. From these
few examples, it is apparent that the thiol is subject to unique
biological chemistry and is often the site of a diverse array of
modifications that include the covalent intermediate we
observed in APS reductase.
The Role of the Iron-Sulfur Center in APS Reductase
All sulfonucleotide reductases analyzed in this study
utilized the same overall two-step strategy to catalyze
sulfonucleotide reduction. Nevertheless, there are clear
differences between APS and PAPS reductases. Specifically,
these two classes of enzymes differ in the presence of the
iron-sulfur center; APS reductases contain a 4Fe-4S cluster
that is notably absent from PAPS reductases. The logical
question that emerges from this difference is: What role does
the iron-sulfur cluster play in APS reductase?
In this study, we observed ions of M. tuberculosis APS
reductase that have a measured mass in excellent agreement
with the theoretical mass expected for the apoenzyme and the
2Fe-2S intermediate. In support of this assignment, it has
recently been demonstrated that exposure to oxygen gen-
erates the apo and 2Fe-2S cluster forms of B. subtilis
Table 3. Mass Measurements of Wild-Type and Mutant E. coli PAPS and P. aeruginosa APS Reductases Labeled with VP
Enzymea Measured Massb Dmc Modification
E. coli reductase 30,112.4 (30,112.6) 105.2 1 VP
Cys239Ser E. coli reductase 29,991.3 (29,991.5) 0 N/A
E. coli reductase þ PAPS 30,087.2 (30,087.5) 80.0 SO3
Wild-type P. aeruginosa reductase 31,384.7 (31,384.8) 105.1 1 VP
Cys256Ser P. aeruginosa reductase 31,263.8 (31,263.6) 0 N/A
Wild-type P. aeruginosa reductase þ APS 31,359.6 (31,359.7) 80.0 SO3
aIn reactions that contained APS or PAPS, substrate was incubated with enzyme prior to addition of VP.
bMasses (reported in Da) were calculated using the deconvolution function of the Q-TOF micro Masslynx software. The theoretical values are shown in parenthesis.
cMass differences were calculated with respect to the masses of corresponding intact proteins.
N/A, not applicable.
DOI: 10.1371/journal.pbio.0030250.t003
Figure 12. Mechanism of Sulfonucleotide Reduction
DOI: 10.1371/journal.pbio.0030250.g012
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sulfonucleotide reductase [19]. In contrast to M. tuberculosis
APS reductase holoenzyme, these ions do not undergo any
mass shift upon addition of substrate. Thus, forms of APS
reductase that appear to lack a mature cofactor did not form
a stable association with substrate (in contrast to that
observed with the Cys249Ser mutant [Figure 8]) or catalyze
the formation of the enzyme-thiosulfonate intermediate.
These observations are also consistent with previous studies
that have correlated the loss of iron with loss of APS
reductase activity [18,19]. One explanation for these data is
that the loss of cofactor could result in gross active site
structural perturbation with concomitant disruption of
substrate binding interactions. However, an alternative
possibility is that a direct interaction between the iron-sulfur
cluster and APS is required for binding. An intriguing
corollary of this model could be that PAPS reductases
compensate for the lack of this cofactor through additional
binding energy gained from the 39-phosphate moiety of
PAPS. In support of this second proposal, all APS reductases
reported on thus far exhibit a decrease in activity over time
that correlates with decomposition of the iron-sulfur cluster
[12,17–19,22]. In one such study, the addition of AMP to L.
minor APS reductase storage buffer prevented this loss of
enzyme activity [17]. A plausible explanation for the addi-
tional stability is that the terminal phosphate of AMP
interacts with the cluster, preventing oxidation and stabiliz-
ing enzyme activity. By analogy, the sulfate moiety of APS
could also interact with the cluster.
Inspection of the motif that serves as a marker for the iron-
sulfur cluster in APS reductases reveals the presence of an
unusual cysteine pair—Cys140 and Cys141 (using M. tuber-
culosis APS reductase numbering). This Cys-Cys tandem motif
is atypical within the family of iron-sulfur cluster-containing
proteins and has therefore spurred debate as to the number
of cysteines that ligate the 4Fe-4S cluster. Mo¨ssbauer
spectroscopy has been used to probe the cluster in L. minor
and P. aeruginosa APS reductases [12,18]. In these experiments,
only three of the four iron sites exhibited similar Mo¨ssbauer
parameters. Therefore, the authors concluded that the APS
reductase 4Fe-4S cluster is ligated by three cysteines. While
there is no doubt that the iron-sulfur cluster in APS reductase
exhibits unusual spectroscopic properties, alternative inter-
pretations of these data with respect to cluster coordination
are possible. The cysteine-labeling studies carried out in this
study serve as an independent test of the three-cysteine
theory. If only three cysteines participate in iron-sulfur
coordination, the simplest expectation would be that two
covalent modifications could occur—on Cys141 and Cys249.
However, we found that M. tuberculosis Cys59Ser and wild-type
P. aeruginosa APS reductases incorporated only one cysteine
modification, specifically at Cys249. These cysteine-labeling
data would be consistent with a role for Cys141 in iron-sulfur
cluster ligation.
Kim et al. [22] have recently reported on the reaction of P.
aeruginosa APS reductase with dithio-1,4-nitrobenzoic acid
(DTNB). In this experiment, reduction of DTNB gave rise to a
spectroscopic signal that was proposed to represent the
presence of two free thiols in P. aeruginosa APS reductase. As
noted above, the data in the present study indicate that P.
aeruginosa APS reductase has only one free thiol—Cys249. The
experiments reported in this work have probed for free thiols
using the alkylating reagents VP and iodoacetamide. After the
labeling reaction, covalent modifications were quantified by
mass spectroscopy. In addition, the identity of labeled
cysteines was unambiguously established using site-directed
mutagenesis. Unfortunately, quantitation of free thiols by
measuring the release of 5-thio-2-nitrobenzoate (TNB) from
DTNB by monitoring the absorbance at 412 nm allows for
determination only of total thiol content in a sample. In the
absence of additional experiments to confirm that a protein
cysteine residue has been labeled, and that this label can be
eliminated via site-directed mutagenesis, it is not possible to
establish the basis of the TNB signal. For example, iron-
sulfur cluster oxidation occurs normally under aerobic
conditions and produces free sulfide. Since every mole of
APS reductase protein is normally associated with 4 moles of
sulfide, decomposition of the cluster can result in significant
concentrations of sulfide in the sample [25]. Free sulfide is
very reactive, and if present during a DTNB assay, will
generate TNB signal that is not attributable to free protein
cysteine thiol content [43]. Furthermore, the study by Kim et
al. [22] purified P. aeruginosa APS reductase only via affinity
chromatography. In the current work, enzymes were purified
in an additional step using size-exclusion chromatography. It
is also possible, then, that differences in protein preparation
could contribute to the observed discrepancy. Interestingly,
our analysis indicated that P. aeruginosa APS reductase was a
homotetramer (Figure S1A).
Additional data obtained from site-directed mutagenesis of
Cys140 and Cys141 also support a role for these cysteines in
cluster coordination [18,22]. Mutation of Cys140 to serine in
P. aeruginosa APS reductase results in an enzyme with little
detectable iron incorporation. The same mutation to Cys141
results in a less dramatic phenotype, with a 20% decrease in
iron and a 35% decrease in sulfide content assayed soon after
purification. However, the long-term stability of the iron-
sulfur cluster is substantially decreased in the context of the
Cys141 mutant as compared to the wild-type enzyme. One
explanation for the enhanced short-term stability of the iron-
sulfur cluster in P. aeruginosa Cys141Ser mutant could involve
the homotetrameric nature of this enzyme. Such a higher
order assembly could provide stabilizing protein-protein
contacts for the iron-sulfur cluster. This hypothesis is
supported by the finding that cluster loss in the P. aeruginosa
Cys141Ser mutant was more rapid at lower protein concen-
trations [22].
Figure 13 illustrates a model that can account both for the
unusual properties of the cluster and the role we propose for
it in substrate binding. While the Cys-Cys motif is uncommon,
a recent computational study has suggested that it is
theoretically possible for each of these cysteines to ligate
different iron atoms within the same cluster [44]. In addition,
the importance of each of the four cysteines is strongly
suggested by the cysteine-labeling and site-directed muta-
genesis experiments detailed above. Therefore, we propose
that in the absence of substrate, each cysteine would
participate in cluster coordination. However, the interaction
with Cys141 would be unique because of the geometrical
constraints imposed by the neighboring cysteine and its own
interaction with the cluster. When APS binds the reductase,
the oxygens on the sulfate moiety could displace Cys141. In
our cysteine-labeling experiments, the addition of substrate
blocks labeling by VP; no additional labels are obtained. Thus,
for the displacement model to hold true, reaction of VP with
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the liberated Cys141 would have to be prohibited, for
example by the acquisition of a new binding interaction.
Alternatively, Cys141 could remain bound, and the additional
binding of APS would augment the coordination sphere of
the metal. In either scenario, once the substrate is bound, we
propose that the unique iron in the cluster acts as a Lewis
acid by activating the substrate for subsequent nucleophilic
attack and by stabilizing the developing negative charge. A
similar role for iron-sulfur cluster participation in substrate
binding and activation has been demonstrated for aconitase
[45]. This enzyme contains an iron-sulfur cluster with a
unique iron site bound by three cysteine ligands and a water
molecule. During the conversion of citrate to isocitrate, the
terminal oxygen atoms of the substrate interact with this
unique iron. However, in our model for APS reductase we are
proposing a ‘‘substrate-activated’’ aconitase-like arrangement
in which the fourth iron interacts with Cys141; APS binding
to the cluster would result in the displacement or shift of this
cysteine. An important requirement for iron-sulfur cluster
involvement in substrate binding and/or catalysis is that the
cluster resides near the active site. Unfortunately, no
structural data on assimilatory APS reductases are currently
available. However, two studies have reported structural
modeling via sequence homology using the crystal structure
of E. coli PAPS reductase for P. aeruginosa and B. subtilis APS
reductase [19,22]. These models position the cysteines
implicated in cluster ligation within the vicinity of the
enzyme active site. Thus, the location of the cluster would
be consistent with our proposed catalytic function. Never-
theless, additional biochemical investigation together with
high-resolution structural information on APS reductase will
be required to probe the model presented in Figure 13 in
further molecular detail.
Summary
The evolutionary relatedness within the family of sulfonu-
cleotide reductases has been strongly suggested by sequence
homology. Nevertheless, issues of differing substrate specific-
ity, the presence or absence of an iron-sulfur cofactor and the
continued conflict in the literature with respect to mecha-
nism had obscured this vision. Hence, the general mechanism
of sulfonucleotide reduction established in this work revali-
dates the evolutionarily relatedness of these enzymes and will
help inform future studies to address the experimental
challenges outlined above, such as structural characterization,
identification of the determinants that govern substrate
specificity, and the catalytic involvement of the iron-sulfur
cluster. Finally, given that discrete snapshots in the evolution
of sulfonucleotide reduction have been biologically re-
tained—APS reductases containing an iron-sulfur cofactor
(M. tuberculosis), the bispecific APS and PAPS reductase
containing an iron-sulfur cofactor (B. subtilis), and PAPS
reductases without an iron-sulfur cluster cofactor (E. coli)—we
are presented with an exciting opportunity to probe more
general questions regarding the evolution of catalytic
diversity in the work to come.
Materials and Methods
Materials. Nonradioactive APS was purchased from Biolog Life
Sciences Institute, (Bremen, Germany). [35S]SO4
2 (specific activ-
ity1,491 Ci/mmol) was obtained from MP Biochemicals (Irvine,
California, United States). Molecular biology grade DTT was from
Invitrogen (Carlsbad, California, United States). Nonradioactive
PAPS, TCEP, and E. coli thioredoxin protein were all purchased from
EMD Biosciences (San Diego, California, United States). VP, bis-tris
propane, methionine, and iodoacetamide were all purchased from
Sigma-Aldrich (St. Louis, Missouri, United States). Depending upon
availability, PEI-cellulose thin-layer chromatography (TLC) plates (20
cm 3 20 cm) were purchased from J. T. Baker (Phillipsburg, New
Jersey, United States) or EMD Biosciences. Pfu and DpnI polymerase
were from Stratgene (La Jolla, California, United States). Restriction
enzymes and T4 DNA ligase were from New England Biolabs (Beverly,
Massachusetts, United States). All other chemicals were purchased
from J. T. Baker and were of the highest purity available ( 95%).
DNA oligonucleotides were purchased from Qiagen (Valencia,
California, United States).
Preparation of the sulfonucleotide reductase expression vectors.
Table S1 lists the oligonucleotides used in this study. The gene
encoding the M. tuberculosis APS reductase was amplified from H37Rv
M. tuberculosis genomic DNA and cloned in a protein expression
vector as described [3]. The gene encoding M. smegmatis APS
reductase was amplified from M. smegmatis genomic DNA. The gene
encoding P. aeruginosa APS reductase was amplified from P. aeruginosa
genomic DNA ATCC 47085D (ATCC, Manassas, Virginia, United
States). The gene encoding E. coli PAPS reductase was amplified from
E. coli genomic DNA ATCC 700926 (ATCC). PCR reactions contained
0.25 lM of each primer, 10–100 ng of genomic DNA template, and 2.5
units of Pfu DNA polymerase in reaction buffer supplied by the
manufacturer. PCR was performed in a PTC-200 thermocycler (Bio-
Rad Laboratories, South San Francisco, California, United States)
using the following program: 2 min at 95 8C; 30 cycles of 30 s at 95 8C,
1 min at 55 8C, and 1 min at 68 8C; and a 5-min extension at 68 8C. In
some cases, the annealing temperature had to be adjusted in order to
achieve the desired product. PCR reactions were screened for the
expected DNA fragment via agarose gel electrophoresis. Subse-
quently, each PCR fragment was ligated into a Zero Blunt Topo
cloning vector (Invitrogen) and subsequently digested by NdeI and
XhoI (pET24b) or NdeI and BamHI (pET14b). Alternatively, the PCR
fragment was directly digested without additional cloning steps. The
purified gene fragment was then ligated into a NdeI- and XhoI-
digested, CIP-treated pET24b or a NdeI- and BamHI-digested CIP-
treated pET14b vector using T4 DNA ligase. The ligation reaction was
transformed into chemically competent XL-1 Blue cells (Stratagene).
After growth on LB plates containing 50 mg/ml kanamycin (pET24b)
or 100 mg/ml ampicillin (pET14b), colonies were selected and
cultures were grown up overnight. Plasmid DNA minipreps were
screened for the presence of the gene by PCR. DNA sequencing using
forward T7 and reverse T7 primers was performed to confirm the
identity of the desired gene product.
Figure 13. Proposed Role of the Iron-Sulfur Cluster in APS Reduction
DOI: 10.1371/journal.pbio.0030250.g013
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Site-directed mutagenesis. Site-specific mutations were made using
Quik Change PCR mutagenesis kit (Stratagene) using the appropriate
plasmid template according to the manufacturer’s specifications. The
DNA oligonucleotides used in these reactions are listed in Table S1.
Successful incorporation of the desired mutation was confirmed by
sequencing and once verified, the plasmid was transformed into
BL21(DE3) (Novagen, San Diego, California, United States) for
protein expression as described above.
Expression and purification of sulfonucleotide reductases. Proteins
were expressed by transforming a reductase-containing plasmid into
BL21(DE3) cells (Novagen) and grown on LB-agarose containing 50
mg/ml kanamycin. An isolated colony was grown in 5 ml of LB broth
containing 50 mg/ml kanamycin. The culture was grown at 37 8C
overnight. This culture was used to inoculate 1 l of LB broth
containing 50 mg/ml kanamycin. The culture was grown with shaking
(250 rpm) at 37 8C to an OD of 0.6, and IPTG was added to a final
concentration of 0.4 mM. The shaker flasks were then shifted to18 8C
and grown 12–16 h. Subsequently, 1 l of cells were collected by
centrifugation and resuspended in 30 mls lysis buffer (20 mM sodium
phosphate [pH 7.4], 0.5 M NaCl, 10 mM imidazole, and 1 mM
methionine) together with an EDTA-free protease inhibitor tablet
(Roche, Indianapolis, Indiana, United States) before disruption by
sonication on ice. After sonication, DNase and RNase (Sigma) were
added to the lysate at 10and 5 lg/ml, respectively, and stirred for 10
min on ice. The cell lysate was cleared by centrifugation and the
supernatant was applied to a 1 or 5 ml HiTrap Chelating column
(Amersham, Piscataway, New Jersey, United States). The column was
washed with ten column volumes in 20 mM phosphate (pH 7.4), 0.5 M
NaCl, and 50 mM imidazole, and was eluted with 20 mM phosphate
(pH 7.4), 0.5 M NaCl, and 250 mM imidazole. Fractions containing the
desired protein were pooled and concentrated using Amicon 10,000
Da molecular weight cutoff centrifugal filters (Millipore, Billerica,
Massachusetts, United States) prior to injection onto a 10/30
Superdex 200 or a 16/60 Superdex 200 prep grade gel filtration
column. The standard gel filtration buffer was 50 mM Tris-HCl (pH
8.0), 10% glycerol, and 5 mM DTT with ionic strength adjusted to 150
mM with NaCl. The inclusion of DTT in the gel filtration buffer for
sulfonucleotide reductases purification has been well established [14–
16]. DTT was included in the gel filtration buffer to slow down
oxidation and decomposition of the iron-sulfur cluster. No change in
retention volume during size exclusion chromatography was ob-
served with any of the proteins purified for this study when DTT was
omitted from the buffer. Fractions containing sulfonucleotide
reductase were pooled, aliquoted into single-use portions, snap-
frozen in liquid nitrogen, and stored at 80 8C. Protein concen-
trations were determined precisely by quantitative amino acid
analysis (AAA Service Laboratory, Boring, Oregon, United States).
Iron content, typically  3.5 mol iron/mol protein, of each
preparation was determined as previously described [46,47].
Untagged M. tuberculosis APS reductase was expressed as reported
above. Cells from 1 l of bacterial culture were resuspended in 30 ml of
20 mM bis-tris propane (pH 7.0) and lysed by sonication. The
resulting lysate was clarified by centrifugation, and the supernatant
was applied to a 5-ml Fast Flow Q anion exchange column
(Amersham). The column was washed with ten column volumes of
lysis buffer, and proteins were eluted over ten column volumes with a
salt gradient of 0–1 M NaCl. Column fractions were assayed for APS
reductase activity and for absorbance at 390 nm to detect the iron-
sulfur cluster. APS reductase eluted between 250 and 350 mM NaCl.
APS reductase-containing fractions were pooled and ammonium
sulfate added to a final concentration of 30%. APS reductase activity
was retained in the supernatant. Proteins that precipitated at 30%
ammonium sulfate were removed by centrifugation. Ammonium
sulfate was added to a final concentration of 70% to precipitate APS
reductase. The protein pellet was resuspended in gel filtration buffer
and was further purified by size exclusion chromatography, as
described above.
Synthesis of [35S]APS and [35S]PAPS. 35S-labeled APS and PAPS
were prepared by incubating [35S]Na2SO4, ATP, ATP sulfurylase(Sig-
ma), inorganic pyrophosphatase (Sigma), and recombinant APS
kinase together as previously described [48,49]. Analysis of the
reaction by PEI-cellulose TLC plates developed in 1 M LiCl indicated
complete conversion of [35S]SO4
2 to [35S]PAPS. The reaction was
then terminated by heating for 2 min in a boiling water bath. The
precipitate formed was removed by centrifugation. [35S]PAPS was
further purified by treatment with activated charcoal as previously
described [50]. For the synthesis of [35S]APS, nuclease P1 was
incubated with the [35S]PAPS reaction supernatant for 30 min at
room temperature. Complete conversion of [35S]PAPS to [35S]APS was
verified by TLC and [35S]APS further purified as above. Single-use
aliquots of [35S]APS and [35S]PAPS, always containing less than 1.5%
contaminating [35S]SO4
2 , were stored at 80 8C. Minimizing the
amount of [35S]SO42 present in the substrate served only to facilitate
product quantification, as sulfate had no observed effect on reaction
rates at concentrations measured into the millimolar regime.
Furthermore, while APS is susceptible to nonenzymatic hydrolysis
of APS to sulfate and AMP, this reaction was undetectable over the
time scale of our assays as measured in reactions that contained only
APS or APS incubated with the catalytically inactivated M. tuberculosis
APS reductase Cys249Ser mutant.
General kinetic methods. Reactions were performed at 30 8C in
assay buffer (50 mM sodium phosphate [pH 7.0], adjusted to 100 mM
ionic strength with NaCl) unless noted otherwise. Nonradioactive
PAPS or APS were doped with a trace amount of [35S]APS or
[35S]PAPS. Different buffers were used at the same pH value to test
for buffer-specific effects on reductase activity. No significant buffer
effects on enzymatic activity were observed. Reactions were
performed at pH 7.0, the pH value of the maximal rate based on
the observed pH dependence of M. tuberculosis APS reductase
(unpublished data). Multiple turnover reactions contained 10 lM
thioredoxin and 5 mM DTT and were typically initiated by the
addition of APS or PAPS. As shown by the data presented in Figures
10 and 11 and Table 2, DTT was unable to reduce the thiosulfonate-
enzyme intermediate. DTT was included in multiple turnover
reactions to regenerate the thioredoxin that becomes oxidized as a
consequence of APS reduction (Figure 2). While multiple turnover
reactions are typically followed using initial rates, with the exception
of very slow or undetectable reactions, we followed our reactions to
completion (five half-lives or more). For the purposes of these assays,
inhibition by AMP product did not have a significant effect upon the
reaction rates measured. The reaction progress curve was plotted as a
function of time, and the fractional extent of reaction and fit by a
single exponential (Kaleidagraph, Synergy Software, Reading, Penn-
sylvania, United States). Good first-order fits to the data with end
points of 90% were obtained (R2  0.98). The kinetic data presented
in each figure were measured in at least three independent experi-
ments to ensure reproducibility of results.
TLC-based assay for sulfonucleotide reduction. Traditionally,
sulfonucleotide reductase activity has been quantified by quenching
the [35S]SO3
2 producing reaction with 2 M sulfuric acid, together
with a large excess of cold sulfite, to yield [35S]-labeled sulfoxide gas
[13,28]. The reaction vessel is rapidly placed into a vial containing an
organic base, such as octyl amine, to trap the gas. The vial is closed
and incubated overnight to maximize gas absorption. Subsequently,
the amount of trapped radiolabeled sulfide is quantified by
scintillation counting.
While the original assay continues to be in use, a TLC-basedmethod
has more recently been developed that avoids the production of
radioactive gas and allows analysis of results on a faster time scale [16].
Perhaps most importantly, the fraction of reaction can be directly
determined by quantifying both substrate and product spots as
visualized by TLC, which helps to minimize quantification of reaction
artifacts and improves the accuracy of measured rates [51]. In this
method, a 2-min heat-kill step is used to terminate the sulfonucleotide
reductase reaction and is followed by analysis on PEI-cellulose TLC
plates developed in 1 M LiCl. To facilitate kinetic analysis of
sulfonucleotide reductase activity, we have modified this assay slightly
based on methods developed by Peluso et al. to measure GTPase
activity [52]. Our modification has been designed to take advantage of
the fact that sulfonucleotide reductase activity is pH-dependent; no
detectable activity was observed below pH 5 for any of the
sulfonucleotide reductases used in this study. At specified times, an
aliquot was removed from the reaction mixture and quenched with
0.75 M potassium phosphate (pH 3.3). The products and unreacted
substrate were then separated by TLC on PEI-cellulose plates
(prepared by prewashing for 5 min in 10% NaCl, followed by three
5-min washes in water and then drying) and developed in 1 M LiCl and
0.3 M sodium phosphate (pH 3.8). Control reactions showed that the
quench rapidly extinguished all reductase activity. Under aerobic
conditions, free sulfite product naturally oxidizes to sulfate. The rate at
which this oxidation occurs is enhanced both by low pH and by the
presence of metal ions. Thus, termination of the reaction with the low
pH quench and subsequent development in the running buffer
described above converts the free [35S]SO3
2 product gener-ated in
the enzymatic reaction quantitatively into [35S]SO4
2 . The product
was then quantified as [35S]SO4
2 . Addition of 1 mM MgSO4 to the
quench buffer improved the resolution of substrate and product on
the PEI-cellulose plates. TLC plates were analyzed using Phosphor-
imager analysis (Amersham) with Image Quant quantitation software.
In side-by-side experiments, reaction rates measured using the low-pH
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quench were within experimental error (6 15%) of the previously
published heat-kill assay. Representative data for this modified TLC
assay are presented in Figure S6.
Measurement of intermediate formation by TLC. For reactions in
which multiple turnover was not desired, thioredoxin was omitted
from the reaction mixture. Sulfonucleotide reductase enzyme was
used at concentrations in the high nanomolar to low micromolar
range to detect a single turnover. Under conditions that had
quantitatively produced the thiosulfonate intermediate, E-SO3
, as
observed by mass spectrometry and gel labeling, a new signal on the
TLC plate was observed as a discrete spot at that remained the origin
of the TLC plate (see Figure S5). In these experiments, intermediate
formation was followed in two ways. Since radiolabel would be
transferred from substrate to enzyme upon intermediate formation,
in the first method we quantified the decrease in APS over time. In a
second method, we quantified the appearance of the new spot at the
TLC origin, which was assumed to be E-SO3
. For each enzyme
concentration, the reaction endpoint was determined at the point
where no further substrate was consumed or intermediate was
formed. The endpoint of each reaction (quantified either as fraction
APS consumed or as fraction intermediate formed) was plotted as the
ratio of enzyme to substrate concentration. As expected, the amount
of substrate consumed was identical to the amount of new spot
generated, and either treatment of the data yielded the same results.
Analytical ultracentrifugation. Sedimentation equilibrium experi-
ments were conducted using a Beckman XL-I analytical ultra-
centrifuge (Beckman Instruments, Fullerton, California, United
States). Purified M. tuberculosis APS reductase protein in gel filtration
buffer was analyzed at concentrations ranging from 5 to 30 lM at 4
8C. All concentrations analyzed gave very similar molecular weights.
In independent experiments, samples were centrifuged at speeds
ranging from 20,000 to 30,000 rpm, and the absorbance versus radial
distribution was determined between 380 and 400 nm, the wavelength
region in which the iron-sulfur cluster cofactor bound to the enzyme
absorbs. Absorbance data were obtained at the wavelength indicated
and at radial increments of 0.003 cm, each data point being an
average of three measurements. Data were acquired at intervals over
a period of 18 h, with scans at 3-h intervals to ensure that the system
had attained equilibrium. Equilibrium distributions were then
acquired at 0.001-cm radial increments, each data point being the
average of five measurements. The sedimentation equilibrium data
were analyzed using a vbar of 0.729 calculated from the amino acid
composition, a calculated solvent density of 1.026, and best fit to a
model of a single ideal species using a data analysis program supplied
by Beckman.
4-vinylpyridine and iodoacetamide labeling. N-methylmorpholine
at final concentration of 10 mM was added to approximately 1 mg/ml
protein concentration in gel filtration buffer. Under reducing
conditions, either 2 mM TCEP or 5 mM DTT was used. Results
obtained were independent of reducing agent used. VP was then
added at 2- to 100-fold excess per mole of cysteine residues. The
cysteine-labeling reaction proceeded in the dark at room temper-
ature for 60 min and was terminated by snap freezing in liquid
nitrogen. For the reactions with substrate, sulfonucleotide was added
at a 2- to 5-fold excess concentration per protein monomer prior to
the addition of VP. Reactions with iodoacetamide were performed as
above, except that iodoacetamide was used at 25 mM final
concentration. Labeled samples were buffer-exchanged into NH4OAc
as described below to remove small molecule reagents, and then
diluted with 80:20 acetonitrile:water containing 1% formic acid for
mass analysis.
Buffer exchange and sample preparation for mass spectrometry.
Aliquots (100 ll) of purified sulfonucleotide reductase or thioredoxin
were buffer exchanged into 50 mM NH4OAc (pH 7.5), using Amicon
10,000 Da molecular weight cutoff centrifugal filters with the
temperature of the centrifuge set at 4 8C. The buffer was exchanged
three times, and the final protein concentration was determined
using Bradford assay. Stock solutions of APS, PAPS, and DTT were
prepared in 50 mM NH4OAc as well. To generate reduced
thioredoxin, a ten-fold molar excess of DTT was incubated with the
protein for 15 min on ice. Mass analysis was performed to confirm the
expected þ2 Da shift, relative to oxidized thioredoxin. For enzyme-
substrate incubation experiments with M. tuberculosis APS reductase,
appropriate volumes of each component were mixed in the NH4OAc
buffer and the mixtures were chilled on ice for at least 15 min before
being introduced into the mass spectrometer. For the trypsin digest
of APS reductase, 15 lM APS reductase was incubated in 50 mM
NH4OAc (pH 7.5) with and without 10 molar excess APS at room
temperature for 1 h with 0.4% (w/w) sequence grade trypsin. Some
mixtures were further diluted with 80:20 acetonitrile:water contain-
ing 1% formic acid to detect possible covalent modifications
(denatured mass analysis). For the experiments designed to observe
intermediate formation and release with E. coli PAPS reductase and P.
aeruginosa APS reductase, incubations were carried out for 15 min at
the following concentrations: 10 lM enzyme, 100 lM APS or PAPS, 5
lM thioredoxin, and 50 lM DTT. After incubation, samples were
dissolved in 80:20 acetonitrile:water containing 1% formic acid for
mass analysis.
Mass spectrometry. Mass spectrometry data for M. tuberculosis APS
reductase were acquired on a Bruker FT-ICR MS (Bruker, Billerica,
Massachusetts, United States) equipped with an actively shielded 7
tesla superconducting magnet. Solutions were infused at a rate of 2
ll/min into an Apollo electrospray source (Bruker) operated in the
positive mode. To analyze the enzyme and its reaction mixture in the
native state, the syringe pump and spray chamber were wrapped with
ice bags to prevent the protein sample from precipitating out of
solution. The N2 nebulizing and drying gas pressure was maintained
at 50 and 25 psi, respectively. The bias on the glass capillary was kept
at 4,600 V, and 140 8C drying gas was used to assist in the desolvation
process. Further desolvation was achieved by collisions of the ions
with neutral buffer gas at the nozzle-skimmer region using a ;180-V
capillary exit voltage. A throttle valve was installed at the nozzle-
skimmer region to adjust the pressure to approximately 1 3 106
mbar. Ions were externally accumulated in a radio frequency-only
hexapole for 1 s before transfer into the ICR cell. Excessive kinetic
energy was removed by colliding the ions with Argon pulsed into the
cell to a pressure of approximately 1 3 108 mbar. Usually for one
transient, two loops of Argon pulse were applied with a series of
pump downs applied to lower the pressure in the cell to
approximately 1 3 1010 mbar before ion detection. All ions were
collected using gated trapping and detected using chirp excitation
and broad band data acquisition using an average of 16–64 time
domain transients containing 32 K or 1 M data points. The original
time domain free induction decay spectra were zero filled, Gaussian-
multiplied and Fourier transformed. All the data were acquired and
processed using Bruker Xmass version 6.0.0 software. The parameters
of the ESI source, ion optics and cell were tuned for the best signal-
to-noise ratio and were kept the same for systematic experiments.
Mass spectrometry data for E. coli PAPS reductase and P. aeruginosa
APS reductase were acquired on a Q-TOF micro mass spectrometer
(Waters, Milford, Massachusetts, United States) with electrospray
source operated in positive mode. The spray probe used was silicon
capillary, which was drawn down to a fine taper above a flame and cut
manually to give the required diameter and flow. Samples were
infused at a flow rate of 3 ll/min. The ESI source voltages were as
follows: 3,200 V capillary, 35 V sample cone, and 1.5 V extraction
cone. Source temperature was kept at 120 8C and analyzer pressure
read-back was 4.53 105 mbar. A denatured myoglobin solution was
used as the calibrant solution. The acquisition range was 500–2,500 m/
z with an acquisition step of 1.2 s. All spectra were processed using
MassLynx software (Waters).
Supporting Information
Figure S1. Gel Filtration Profile of Wild-Type and Mutant M.
tuberculosis APS Reductase, E. coli PAPS Reductase, and P. aeruginosa
APS Reductase
(A) Superdex 200 protein profile of M. tuberculosis APS reductase
(filled circles), E. coli PAPS reductase (filled squares) and P. aeruginosa
APS reductase (filled diamonds) followed by absorbance at 280 nm.
Inset shows the calibration of the Superdex 200 column with known
protein standards (blue dextran 2,000,000 Da, thyroglobulin 670,000
Da, bovine IgG 158,000 Da, human IgG 150,000 Da, bovine serum
albumin 67,000 Da, ovalbumin 44,000 Da, chymotrypsin 25,000 Da,
myoglobin 17,000 Da, and ribonuclease A 13,700 Da). Based on
elution volume, the molecular weight (calculated from the standard
curve of known protein standards) of M. tuberculosis APS reductase is
34,033 Da, E. coli PAPS reductase is 69,085 Da, and P. aeruginosa APS
reductase is 128,078 Da. For each sulfonucleotide reductase the gel
filtration profile of the catalytic cysteine to serine mutant has also
been plotted (M. tuberculosis, open circles; E. coli, open squares; and P.
aeruginosa, open diamonds).
(B) ESI-mass spectrometry spectrum of 10 lM APS reductase in 50
mM NH4OAc. Three charge states are observed, 9þ, 10þ and 11þ. The
calculated mass is 28,706.00 Da using the deconvolution function on
the Bruker Xmass software.
Found at DOI: 10.1371/journal.pbio.0030250.sg001 (2.3 MB EPS).
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Figure S2. Gel Filtration and Activity Profile of Untagged and His-
Tagged M. tuberculosis APS Reductase
(A) Superdex 200 profile of untagged M. tuberculosis APS reductase,
purified in prior steps by anion exchange and ammonium sulfate
fractionation, was followed by analysis of absorbance at 390 nm to
detect the iron-sulfur cluster (solid line). The predicted molecular
weight of the major peak is 34,334 Da, close to the expected value of
27,638 Da. Assay of untagged M. tuberculosis APS reductase activity
across the gel filtration column (dashed line) as described in Materials
and Methods.
(B) Activity of His-tagged M. tuberculosis APS reductase plotted in
conjunction with absorption at 390 nm.
Found at DOI: 10.1371/journal.pbio.0030250.sg002 (708 KB EPS).
Figure S3. Gel Labeling of Wild-Type, Cys59Ser, and Cys249Ser M.
tuberculosis APS Reductase
In this experiment, 5 lM wild type (lanes 1–3), Cys249Ser (lanes 4–6),
and Cys59Ser (lanes 7–9) M. tuberculosis APS reductase was incubated
at room temperature in 50 mM bis-tris propane (pH 7.0), 100 mM
NaCl with [35S]APS only (lanes 1, 4, and 7); with 200 lM APS for 5 min
prior to the addition of [35S]APS (lanes 2, 5, and 8); or with [35S]APS
for 5 min followed by the addition of 10 lM thioredoxin (lanes 3, 6,
and 9). SDS-PAGE load dye (without reductant) was added to
terminate the reaction. The samples were heated at 60 8C for 3 min
and size-fractionated by 12% nonreducing SDS-PAGE. The incorpo-
ration of radioactivity was analyzed with a Phosphorimager.
Found at DOI: 10.1371/journal.pbio.0030250.sg003 (2.1 MB TIF).
Figure S4. Gel Labeling of Wild-Type and Mutant E. coli and P.
aeruginosa Sulfonucleotide Reductases
(A) Gel labeling of wild type (lanes 1–3) and Cys239Ser (lanes 4–6) E.
coli PAPS reductase was carried out as described in the legend to
Figure S3, except that PAPS was used as the substrate.
(B) Gel labeling of wild type (lanes 1–3) and Cys256Ser (lanes 4–6) P.
aeruginosa reductase was carried out as described in the legend to
Figure S3.
Found at DOI: 10.1371/journal.pbio.0030250.sg004 (1.7 MB TIF).
Figure S5. Intermediate Formation and Sulfite Release by M.
tuberculosis, E. coli, and P. aeruginosa Sulfonucleotide Reductases
(A) Here, 5 lM M. tuberculosis APS reductase (lanes 3–6) or E. coli
PAPS reductase (lanes 9–12) was incubated at room temperature in
50 mM bis-tris propane (pH 7.0), 100 mM NaCl with [35S]APS or
[35S]PAPS in the presence (lanes 5, 6, 11, and 12) or absence (lanes 3,
4, 9, and 10) of 10 lM thioredoxin. Lanes 1, 2, 7, and 8 are control
reactions in which sulfonucleotide reductase and thioredoxin have
been omitted. Each odd lane is a sample of the reaction prior to
addition of sulfonucleotide reductase. Each even lane is a sample
from the reaction that has been terminated 10 min after the
addition of sulfonucleotide reductase. No intermediate release was
observed using 10 mM DTT in place of thioredoxin (unpublished
data).
(B) Experiment exactly as above except with P. aeruginosa APS
reductase.
Found at DOI: 10.1371/journal.pbio.0030250.sg005 (3.7 MB EPS).
Figure S6. Multiple Turnover TLC Assay for Sulfonucleotide
Reduction
(A) TLC analysis to follow the extent of the sulfonucleotide reductase
reaction, as described in Materials and Methods. A complete reaction
progress curve for the reaction of trace [35S]APS, 20 lM APS, 10 lM
thioredoxin, 5 mM DTT, and 20 nMM. tuberculosis APS reductase. The
relative amounts of 35S in the product and substrate spots were
quantified with a Phosphorimager.
(B) The time course of the reaction shown in (A) follows a single-
exponential function.
Found at DOI: 10.1371/journal.pbio.0030250.sg006 (2 MB TIF).
Table S1. Oligonucleotide Primers Used in This Study
Found at DOI: 10.1371/journal.pbio.0030250.st001 (33 KB DOC).
Accession Numbers
Available GenBank accession numbers for the sulfonucleotide
reductase genes discussed in this paper are as follows: M. tuberculosis
(CAB03733.1), R. meliloti (AAD55759.1), P. aeruginosa (AAG05145.1), B.
cepacia (AF170343), L. minor (CAB65911.1), A. thaliana (APR2)
(AAC26977.1), E. coli (BAB37040.1), S. flexneri (AAP18092.1), S. cerevisiae
(AAA34774.1), B. subtilis (CAB13431.1), and B. anthracis (AAT30539.1).
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